Northern Trust
ACHV icon

Northern Trust’s Achieve Life Sciences ACHV Stock Holding History

Northern Trust’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$661K Sell
224,742
-5,137
-2% -$22.8K ﹤0.01% 3503
2025
Q4 		$1.14M Buy
229,879
+10,434
+5% +$45.5K ﹤0.01% 3302
2025
Q3 		$691K Buy
219,445
+3,600
+2% +$9.88K ﹤0.01% 3541
2025
Q2 		$488K Sell
215,845
-188,150
-47% -$536K ﹤0.01% 3659
2025
Q1 		$1.08M Sell
403,995
-12,801
-3% -$39.8K ﹤0.01% 3242
2024
Q4 		$1.47M Buy
416,796
+43,682
+12% +$198K ﹤0.01% 3187
2024
Q3 		$1.77M Buy
373,114
+246,841
+195% +$1.13M ﹤0.01% 3077
2024
Q2 		$593K Buy
126,273
+27,541
+28% +$133K ﹤0.01% 3445
2024
Q1 		$449K Sell
98,732
-3,252
-3% -$14.4K ﹤0.01% 3595
2023
Q4 		$420K Buy
101,984
+23,027
+29% +$100K ﹤0.01% 3600
2023
Q3 		$340K Buy
78,957
+5,379
+7% +$27.1K ﹤0.01% 3626
2023
Q2 		$382K Buy
73,578
+41,673
+131% +$292K ﹤0.01% 3610
2023
Q1 		$217K Buy
31,905
+15,461
+94% +$73.5K ﹤0.01% 3823
2022
Q4 		$40.3K Hold
16,444
– – ﹤0.01% 4333
2022
Q3 		$54K Sell
16,444
-265
-2% -$1.26K ﹤0.01% 4304
2022
Q2 		$81K Sell
16,709
-390
-2% -$2.65K ﹤0.01% 4250
2022
Q1 		$129K Buy
17,099
+85
+0.5% +$633 ﹤0.01% 4270
2021
Q4 		$132K Sell
17,014
-298
-2% -$2.34K ﹤0.01% 4334
2021
Q3 		$147K Buy
17,312
+216
+1% +$1.7K ﹤0.01% 4290
2021
Q2 		$153K Buy
+17,096
New +$163K ﹤0.01% 4241
2020
Q3 		– Sell
-2,040
Closed -$16K – 4293
2020
Q2 		$16K Buy
2,040
+851
+72% +$6.78K ﹤0.01% 4186
2020
Q1 		$8K Buy
+1,189
New +$11.5K ﹤0.01% 4160
2017
Q3 		– Sell
-31
Closed -$25K – 4256
2017
Q2 		$25K Hold
31
– – ﹤0.01% 4162
2017
Q1 		$31K Buy
31
+5
+19% +$6.07K ﹤0.01% 4109
2016
Q4 		$29K Buy
26
+1
+4% +$988 ﹤0.01% 4064
2016
Q3 		$28K Hold
25
– – ﹤0.01% 4074
2016
Q2 		$55K Hold
25
– – ﹤0.01% 3998
2016
Q1 		$37K Hold
25
– – ﹤0.01% 4061
2015
Q4 		$66K Hold
25
– – ﹤0.01% 4010
2015
Q3 		$122K Buy
25
+6
+32% +$36.1K ﹤0.01% 3887
2015
Q2 		$96K Sell
19
-2
-10% -$9.92K ﹤0.01% 3959
2015
Q1 		$101K Sell
21
-1
-5% -$4.91K ﹤0.01% 4033
2014
Q4 		$110K Hold
22
– – ﹤0.01% 3961
2014
Q3 		$128K Sell
22
-54
-71% -$375K ﹤0.01% 3970
2014
Q2 		$627K Sell
76
-17
-18% -$209K ﹤0.01% 3539
2014
Q1 		$2.4M Sell
93
-6
-6% -$147K ﹤0.01% 3022
2013
Q4 		$1.82M Buy
99
+2
+2% +$35.1K ﹤0.01% 3203
2013
Q3 		$1.98M Sell
97
-1
-1% -$20.7K ﹤0.01% 3103
2013
Q2 		$2.12M Buy
+98
New +$2.19M ﹤0.01% 2955

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust's ACHV Position: Q1 2026 in Review

Northern Trust reduced its Achieve Life Sciences (ACHV) stake by 2.2% in Q1 2026, selling an estimated $22.8K and leaving 224,742 shares worth $661K. The position accounts for ﹤0.01% of the portfolio, ranked #3503.

Northern Trust first reported a position in ACHV in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.4M in Q1 2014. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Northern Trust held 224,742 shares of Achieve Life Sciences worth $661K as of Q1 2026.
  • Northern Trust sold 5,137 Achieve Life Sciences shares in Q1 2026, an estimated $22.8K.
  • Achieve Life Sciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3503 holding.
  • Northern Trust first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 39 quarters since.
  • Northern Trust's Achieve Life Sciences position peaked at $2.4M in Q1 2014.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.